Xiao Ming Zhu
Corporate Officer/Principal en MicroPort Cardiac Rhythm Management International Ltd. .
Perfil
Xiao Ming Zhu is currently the General Manager-China Region at MicroPort Cardiac Rhythm Management International Ltd.
Prior to this, he worked as the Marketing Director at Medtronic (Shanghai) Management Co. Ltd.
from 2013 to 2014, and as the Head-Senior Marketing Manager at Edwards (Shanghai) Medical Products Co., Ltd.
from 2011 to 2013.
Zhu received his undergraduate degree from Shanghai Jiao Tong University School of Medicine in 1992.
Cargos activos de Xiao Ming Zhu
Empresas | Cargo | Inicio |
---|---|---|
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01/09/2014 |
Antiguos cargos conocidos de Xiao Ming Zhu.
Empresas | Cargo | Fin |
---|---|---|
Medtronic (Shanghai) Management Co. Ltd.
Medtronic (Shanghai) Management Co. Ltd. Medical DistributorsDistribution Services Part of Medtronic Plc, Medtronic (Shanghai) Management Co. Ltd. provides services and support for medical equipment, including a comprehensive portfolio of ENT office-based sinus surgery solutions and spinal fusion and artificial disc therapies. The company is based in Shanghai, China. The Chinese company offers bone graft options and minimally invasive spinal surgery options for patients. Recently, their MiniMed™ 780G system has been FDA approved, which allows for real-time insulin adjustments and corrections. | Ventas & Marketing | 01/08/2014 |
Edwards (Shanghai) Medical Products Co., Ltd. | Corporate Officer/Principal | 01/09/2013 |
Formación de Xiao Ming Zhu.
Shanghai Jiao Tong University School of Medicine | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |
Edwards (Shanghai) Medical Products Co., Ltd. | |
Medtronic (Shanghai) Management Co. Ltd.
Medtronic (Shanghai) Management Co. Ltd. Medical DistributorsDistribution Services Part of Medtronic Plc, Medtronic (Shanghai) Management Co. Ltd. provides services and support for medical equipment, including a comprehensive portfolio of ENT office-based sinus surgery solutions and spinal fusion and artificial disc therapies. The company is based in Shanghai, China. The Chinese company offers bone graft options and minimally invasive spinal surgery options for patients. Recently, their MiniMed™ 780G system has been FDA approved, which allows for real-time insulin adjustments and corrections. | Distribution Services |
- Bolsa de valores
- Insiders
- Xiao Ming Zhu